HER2-Positive Early Stage Breast Cancer Completed Phase 2 Trials for Pegfilgrastim (DB00019)

Also known as: HER2-Positive Early Breast Cancer / HER2-positive early-stage breast cancer / Early Stage HER2+ Breast Cancer / HER2 Positive Early Breast Cancer

IndicationStatusPhase
DBCOND0063722 (HER2-Positive Early Stage Breast Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01827163Paclitaxel With Trastuzumab and Lapatinib in HER2-Positive Early Stage Breast CancerTreatment